11 - Antimicrobial Resistance 2 Flashcards
What is the microbiome?
Collection of all microbes in a locale of interest
e.g. GI tract, skin
What is genomics? Two types
Genomics: study of genes (DNA in sample of interest)
- Whole genome sequencing: sequencing the genome of an organism of interest
- Metagenomics: sequencing all the DNA in a sample (e.g. host, orgs in samples environment)
What is transcriptomics? Meta-transcriptomics?
Trans: study of the gene readouts (RNA) from a cell/strain of a microbial organism
Meta: active gene expression of a microbial community
What is proteomics? Metabolomics?
Proteo: protein products of the (meta-)transcriptomics
Metabo: metabolic by-products released into the environment
What is the resistome?
Collection of all the ARGs in the microbiome of a given locale of interest
e.g. microbiome of human, plant, animal, soil, water in an environment
How old is the AMR? How do we know?
Ancient
Through metagenomic analysis
Looked at specific resistance genes, there were precursors to the genes
What soil bacteria produces many antibiotics
Actinomycetes (Streptomyces)
including antibiotics Streptomycin, tetracycline, etc
What is the mobilome?
All the genetic elements in a microbiome that can move within a genome and between different genomes
e.g. transposable elements, phages, plasmids, ICEs
How old is the resistome? How do we know
Very old
Looked at 24 Enterococci spp (environmentally persistent, widespread in nature)
Estimates origin of enterococcus as a spp at 425-500 million years ago, with some resistance genes
Regulatory changes to AMU in Canada
- Mandatory surveillance reporting
- No own use importation of medically important antimicrobials
- establishment of license for active pharmaceutical ingredient importnation
- alternative products approval
Policy changes to AMU in Canada
- removal of growth promotion claims
- veterinary oversight (need vet perscriptions)
What are the goals of antimicrobial stewardship
- optimize clinical outcomes while minimizing unintended consequences of AMU
- minimize the selection and dissemination of AMR (Use less drugs = less selection for AMR)
Two types of AMR genes
- Established: well characterized among human and animal pathogens
- Latent: not previously encountered in pathogens
Possible objectives for environmental AMR suveillance
- Curb the spread of resistant organisms
- Sources of human exposure from environment
- Measure environmental contamination
- Screen for changes in AMR abundance
- Detect emerging threats
Environmental AMR contamination comes from what sources?
- Human and animal pharmaceutical manufacturing
- Terrestrial animal waste (manure, runoff)
- Human waste (urine, sewage)
- Aquaculture animal waste